Effects of Escitalopram on Markers of Bone Turnover: A Randomized Clinical Trial

摘要

Context:Recent observational studies have suggested that the use of selective serotonin reuptake inhibitors is associated with an increased fracture risk and an accelerated bone loss, although conflicting results have been reported. Furthermore, because many of these studies have been performed in depressed women, confounding by indication may influence these findings.